Replies to post #67447 on Anavex Life Sciences Corp (AVXL)

[bas2020]

IF they decide to maintain independence and retain more control, they would still need to partner with a "generic" type drug mfr, which has established distribution channels (not necessarily a name-brand BP like PFE, etc). Perhaps that mfr could provide trial funds. There's also the probability of gov grants. So dilution is not necessarily a given, at least not in the near term.